Generated by GPT-5-mini| Transplantation | |
|---|---|
| Name | Transplantation |
| Specialty | Organ transplant surgery |
| Invented by | Alexis Carrel |
| First performed | Christiaan Barnard |
| Related | Immunology, Surgery, Nephrology |
Transplantation is the medical process of moving cells, tissues, or organs from a donor to a recipient to restore function lost to disease, trauma, or congenital conditions. It encompasses living and deceased donation, autografts, allografts, xenografts, and composite tissue transfers, and integrates surgical technique, immunology, and perioperative care. Major centers, professional societies, and regulatory agencies coordinate practice, research, and allocation across global networks.
Early experimental work in vascular anastomosis by Alexis Carrel and tissue studies at institutions such as Johns Hopkins Hospital enabled limb and organ graft experiments. Landmark milestones include the first successful human kidney transplant at Peter Bent Brigham Hospital between identical twins, the cardiac transplant by Christiaan Barnard at Groote Schuur Hospital, and developments in immunosuppression at research centers like Stanford University and Massachusetts General Hospital. Transplantation programs expanded with advances at institutions including Mayo Clinic, Cleveland Clinic, Mount Sinai Hospital, and international sites such as St. Thomas' Hospital and Karolinska Institute. Regulatory and allocation frameworks emerged under bodies such as United Network for Organ Sharing, National Health Service, and national transplant registries; notable ethical debates involved cases publicized by institutions like Peter Singer’s philosophical commentary and policy discussions at the World Health Organization.
Solid organ transplantation commonly involves renal transplantation at centers like Addenbrooke's Hospital and Royal Free Hospital, liver transplantation programs at King's College Hospital, heart transplantation pioneered at Groote Schuur Hospital, and lung transplantation units at Toronto General Hospital. Vascularized composite allotransplantation includes hand transplantation and face transplantation performed at sites such as Brigham and Women's Hospital and NYU Langone Health. Hematopoietic cell transplantation, including bone marrow and stem cell grafts, is practiced at Fred Hutchinson Cancer Research Center and Dana-Farber Cancer Institute. Xenotransplantation research involves collaborations with institutions like Harvard Medical School and companies such as eGenesis. Autografts and allografts are used in orthopedics at Hospital for Special Surgery and reconstructive surgery at Johns Hopkins Hospital.
Indications include end-stage organ failure managed at specialty centers like Cleveland Clinic for cardiac disease, UCLA Medical Center for pulmonary disease, UCSF Medical Center for hepatic failure, and Mount Sinai Hospital for renal insufficiency. Selection requires multidisciplinary assessment by teams at facilities such as Mayo Clinic and Massachusetts General Hospital, considering comorbidities reviewed in clinics associated with St. Jude Children's Research Hospital and transplant eligibility policies from agencies like Centers for Medicare & Medicaid Services. Psychosocial evaluation draws on guidelines from organizations such as American Society of Transplantation and European Society for Organ Transplantation; candidate prioritization uses allocation systems operated by United Network for Organ Sharing and national waitlists administered by NHS Blood and Transplant.
Surgical innovation spans microsurgical and vascular techniques taught at institutions like Mayo Clinic and Cleveland Clinic and transplant anesthesia protocols developed at Johns Hopkins Hospital. Techniques include orthotopic and heterotopic implantation, organ preservation strategies developed at University of Wisconsin Hospital, and machine perfusion technologies advanced by collaborations with Karolinska Institute and Oxford University Hospitals. Living donor nephrectomy techniques evolved in centers including Toronto General Hospital; minimally invasive and robotic approaches have been implemented at Memorial Sloan Kettering Cancer Center and Mount Sinai Hospital.
Understanding of alloimmunity grew through basic science at National Institutes of Health and immunogenetics mapping at Wellcome Sanger Institute. Immunosuppressive regimens involving calcineurin inhibitors, antiproliferatives, and biologics were developed across research hubs including Stanford University and Yale School of Medicine. Rejection types—hyperacute, acute cellular, and chronic antibody-mediated rejection—are diagnosed using criteria from pathology services at Mayo Clinic and tested with assays standardized by laboratories such as those at Johns Hopkins University. Tolerance induction and desensitization protocols have been trialed at centers like Massachusetts General Hospital and University of Pennsylvania.
Complications range from surgical issues managed by teams at Cleveland Clinic and UCLA Medical Center to infectious complications addressed by infectious disease specialists at CDC and Johns Hopkins Hospital. Long-term outcomes and graft survival statistics are tracked by registries such as United Network for Organ Sharing and analyzed by academic centers like Harvard Medical School and University of Oxford. Issues include chronic rejection, post-transplant lymphoproliferative disorder studied at Fred Hutchinson Cancer Research Center, metabolic complications monitored in clinics at Mayo Clinic, and quality-of-life outcomes researched at Karolinska Institute.
Ethical debates involve allocation frameworks shaped by policy bodies including WHO and national legislatures such as United States Congress; legal frameworks are enforced by agencies like Department of Health and Human Services and national transplant authorities such as NHS Blood and Transplant. Controversies over living donor risk, commercialization, consent, and organ trafficking have prompted international agreements and enforcement involving Interpol and policy advisories from Council of Europe. Social dimensions—disparities in access, cultural attitudes, and public engagement campaigns—have been addressed by charities and advocacy groups such as American Transplant Foundation, British Transplantation Society, and community partners partnering with transplant centers including Mount Sinai Hospital and St. Thomas' Hospital.
Category:Transplant surgery